XOMA (XOMAO) Stock Price, News & Analysis

Company Overview

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Key Stats

• Today's Range: $25.25 to $25.25
• 50-Day Range: $24.97 to $25.39
• 52-Week Range: $23.32 to $25.87
• Volume: 238 shs
• Average Volume: 3,592 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 8.27%
• Price Target: N/A
• Consensus Rating: N/A

XOMAO Stock Analysis - Frequently Asked Questions

How have XOMAO shares performed this year?

XOMA's stock was trading at $25.66 at the start of the year. Since then, XOMAO stock has decreased by 1.5% and is now trading at $25.2740.
View the best growth stocks for 2025 here.

How do I buy shares of XOMA?

Shares of XOMAO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Record date for 4/15 Dividend: 4/03/2025
• Ex-Dividend for 4/15 Dividend: 4/03/2025
• Dividend Payable: 4/15/2025
• Today: 6/17/2025
• Next Earnings (Estimated): 8/11/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:XOMAO
• CIK: 791908
• Web: www.xoma.com
• Phone: 510-204-7200
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $13.05 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A